Whole Body MRI Imaging in Multiple Myeloma at 3 Tesla MRI : Added Value of Diffusion Weighted Imaging

Universitaire Ziekenhuizen KU Leuven

Status: Unknown

Conditions: Multiple Myeloma

Study type: Observational

Funder types: Other

Identifiers

NCT01780766

S51079 (Other Identifier)

FIMM

Details and patient eligibility

About

Whole body MRI with diffusion weighted imaging is a useful imaging tool

• staging and diagnosis
• therapy monitoring All patients will be scanned before and during treatment. The findings on diffusion weighted imaging will be correlated to the golden standard (computer tomography and MRI (T1 and STIR)).

Enrollment: 100 estimated patients

Sex: All

Ages: 25+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients with clinical and laboratory findings, highly suggestive for multiple myeloma.

Exclusion criteria

• All patients who are not allowed to be scanned on MRI (Pacemaker, implants ed.)

Trial design

100 participants in 2 patient groups

Indolent myeloma patient

Symptomatic Myeloma patient